Recent Finacing
Recent Raise
System1 Biosciences develops neurotherapeutics by producing patient-derived three-dimensional cerebral organoids via automated phenotypic screening, collecting multi‑modal longitudinal datasets and deriving deep phenotypes to identify neurological and psychiatric drug targets.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
